Randall Kaye

CIK 1350416 · Executive Vice President & CMO · last filed 2024-12-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.82M

Companies

3

Total Filings

44

Lifetime Open-Market Net

-$2.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Longboard Pharmaceuticals, Inc. (LBPH) Delisted Executive Vice President & CMO 0 $59.98 $0 -$2.09M 9 2024-12-02
AXSM Chief Medical Officer 11,044 $255.17 $2.82M $9.0K 2 2015-12-24
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Sr. VP, Chief Medical Officer 71,940 -$745.7K 33 2011-09-13

Recent Filings · Page 5 of 5

44 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2007-12-17 AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Grant (A) +107,143 $0 EDGAR
2007-12-17 AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Tax (F) −5,148 -$8.5K EDGAR
2007-12-06 AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Grant (A) +107,143 $0 EDGAR
2007-03-22 AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Grant (A) +250,000 $0 EDGAR
Showing 4144 of 44
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.